A few days ago, an insider trading transaction was made. James Filler, the major shareholder and an insider of Century Bancorp Inc obtained precisely 837 shares of Century Bancorp Inc, worth around $66,867 U.S. Dollars, at $79.9 for each one share at the time of the transaction. In the last month, he also purchased 8,401 shares worth $677,474 USD. These insider shares were acquired on January 12, 2018 and the document that contains the original information, filed with the D.C. based-SEC can be found here. The probability of this deal remaining unnoticed is quite small, with the major shareholder presently having ownership of 605,557 shares — that is 13.28% of the total market capitalization of Century Bancorp Inc.
Among 3 analysts covering SteadyMed (NASDAQ:STDY), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. SteadyMed had 7 analyst reports since August 14, 2015 according to SRatingsIntel. H.C. Wainwright initiated the shares of STDY in report on Monday, November 7 with “Buy” rating. The stock has “Buy” rating by RBC Capital Markets on Sunday, August 16. The rating was maintained by H.C. Wainwright with “Buy” on Monday, April 3. As per Wednesday, October 7, the company rating was reinitiated by JMP Securities. RBC Capital Markets maintained SteadyMed Ltd. (NASDAQ:STDY) on Friday, November 13 with “Outperform” rating. The firm has “Outperform” rating by RBC Capital Markets given on Friday, August 14. See SteadyMed Ltd. (NASDAQ:STDY) latest ratings:
10/01/2018 Broker: JMP Securities Rating: Buy
SteadyMed Ltd., together with its subsidiaries, operates as a specialty pharmaceutical firm that focuses on the development and commercialization of drug product candidates for the treatment of orphan and other diseases with unmet parenteral delivery needs. The company has market cap of $92.28 million. The companyÂ’s product candidates are enabled by its proprietary PatchPump, a discreet, pre-filled, water-resistant, and disposable parenteral drug administration technology. It currently has negative earnings. The Company’s lead drug product candidate is Trevyent, a development stage drug that combines PatchPump technology with treprostinil, a vasodilatory prostacyclin analogue for treating pulmonary arterial hypertension.
The stock decreased 0.71% or $0.03 during the last trading session, reaching $3.47. About 12,953 shares traded. SteadyMed Ltd. (NASDAQ:STDY) has risen 139.93% since January 12, 2017 and is uptrending. It has outperformed by 123.23% the S&P500.
Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.01, from 1.29 in 2017Q2. It dived, as 0 investors sold Century Bancorp, Inc. shares while 25 reduced holdings. 10 funds opened positions while 22 raised stakes. 1.94 million shares or 0.45% less from 1.95 million shares in 2017Q2 were reported. Tokio Marine Asset Mgmt holds 8,100 shares or 0.1% of its portfolio. Sei Company owns 5 shares. Acadian Asset Mgmt Limited Com reported 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA). Millennium Ltd Liability Company stated it has 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA). Delphi Mngmt Ma has 11,101 shares. Vanguard Grp Inc Inc has invested 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA). Manufacturers Life Communication The holds 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA) for 3,592 shares. Geode Cap Management Limited Liability Corporation owns 24,241 shares. Royal Retail Bank Of Canada invested 0% in Century Bancorp, Inc. (NASDAQ:CNBKA). Tiaa Cref Investment Mgmt owns 0% invested in Century Bancorp, Inc. (NASDAQ:CNBKA) for 8,569 shares. The Massachusetts-based Rhumbline Advisers has invested 0% in Century Bancorp, Inc. (NASDAQ:CNBKA). Panagora Asset Management reported 8,063 shares. Citigroup Incorporated, a New York-based fund reported 598 shares. Blackrock invested 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA). Fincl Bank Of Ny Mellon reported 32,463 shares stake.
Century Bancorp, Inc. operates as a bank holding firm for Century Bank and Trust Company that provides banking services and products. The company has market cap of $375.93 million. It accepts savings accounts, NOW accounts, demand deposits, time deposits, and money market accounts, as well as cash management accounts. It has a 15.62 P/E ratio. The firm offers single-family and multi-family residential loans, municipal loans, commercial and residential real estate loans, and various consumer loans, as well as provides loans for the construction of residential homes, multi-family properties, commercial real estate properties, and land development.
The stock increased 0.37% or $0.3 during the last trading session, reaching $80.7. About 4,339 shares traded. Century Bancorp, Inc. (NASDAQ:CNBKA) has risen 42.16% since January 12, 2017 and is uptrending. It has outperformed by 25.46% the S&P500.
Since December 12, 2017, it had 7 insider buys, and 0 insider sales for $236,325 activity. $131 worth of Century Bancorp, Inc. (NASDAQ:CNBKA) was bought by SLOANE BARRY R. EVANGELISTA PAUL A bought $170 worth of Century Bancorp, Inc. (NASDAQ:CNBKA) on Monday, December 18. The insider Filler James J bought $134,597.